Point72 Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Point72 Asset Management's NVO Position: Q2 2026 in Review
Point72 Asset Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 29,198 shares worth $1.4M. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in NVO as recently as Q2 2024.
Point72 Asset Management first reported a position in NVO in Q4 2014 and has held it in 11 quarters since. The position peaked at $137M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Point72 Asset Management held 29,198 shares of Novo Nordisk worth $1.4M as of Q2 2026.
- Novo Nordisk was a new Point72 Asset Management position in Q2 2026.
- Novo Nordisk made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2614 holding.
- Point72 Asset Management first reported a position in Novo Nordisk in Q4 2014 and has held it in 11 quarters since.
- Point72 Asset Management's Novo Nordisk position peaked at $137M in Q2 2024.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.